← Back to All Filings

Viatris Director Acquires 24,835 Shares via RSU Vesting

Low SignificanceMarch 10, 2026 at 7:18:00 PM EDT

Viatris Inc

$VTRS4CIK: 0001792044

Subscribe to track VTRS

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Viatris Director Acquires 24,835 Shares via RSU Vesting

Company: Viatris Inc (VTRS) Form: 4 | Filed: 2026-03-10 Significance: Low (Routine Compensation)

Insider: HIGGINS MELINA E Relationship: Director

Transaction Details: • Type: RSU Vesting & Grant • Shares Acquired: 24,835 (Vesting) • Price: $0.00 • Value: $0 (Compensation) • Owned After: 146,048 Direct (+74,000 Indirect)

Key Insight: Routine vesting of restricted stock units and a new annual grant of 15,890 RSUs. No open market activity.

Market Context: Transaction represents <0.01% of the $17.19B market cap.

View Full Filing

Comprehensive Analysis

SEC Filing Analysis: Viatris Inc (VTRS)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: Routine director compensation event involving RSU vesting and a new annual grant; no open market buying or selling detected.
  • Market Impact: Neutral - This is a scheduled compensation event unrelated to current market valuation.

Company Information

FieldValue
CompanyViatris Inc
Ticker SymbolVTRS
CIK0001792044
Market Cap$17.19 Billion
Shares Outstanding1,151,390,000

Insider Information

FieldValue
NameHIGGINS MELINA E
CIK0001162304
RelationshipDirector

Transaction Details

FieldValue
Form Type4
Transaction Date2026-03-06
Transaction CodeM (Exercise/Vesting)
Security TypeCommon Stock
Shares Acquired24,835
Price Per Share$0.00
Total Value$0.00 (Compensation)
Shares Owned After146,048 (Direct)
Indirect Holdings74,000 (By Spouse)

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$0
% of Market Cap0.00%
Shares Transacted24,835
% of Shares Outstanding0.002%
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: With a market cap of $17.19B, this compensation event is mathematically negligible.
  • Ownership Concentration: The insider holds approximately 220,048 shares total (Direct + Indirect), representing roughly 0.019% of the company.
  • Dilution Impact: The vesting of 24,835 shares and new grant of 15,890 RSUs represents nominal dilution (0.003% of outstanding shares).

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: This transaction is purely administrative (vesting of prior awards) and the receipt of a new annual retainer. It does not reflect an investment decision by the director.

Volume & Sentiment

  • Expected Volume Impact: None.
  • Sentiment Indicator: Neutral.

Additional Context

Transaction Notes

  • Vesting: 23,660 RSUs and 1,175 Dividend Equivalent Units vested on March 6, 2026.
  • New Grant: The reporting person also received a new grant of 15,890 RSUs (Code A) which will vest on March 6, 2027.
  • Indirect Ownership: The filer's spouse holds a significant position of 74,000 shares.
Topics:#VTRS#Viatris#SECFiling#InsiderTrading#Form4#PharmaStocks#StockMarket#ExecutiveComp

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.